Genscript Biotech's high P/S ratio is due to its promising r...
Genscript Biotech's high P/S ratio is due to its promising revenue outlook. The company's strong performance and bright future are likely to keep supporting the share price unless conditions change.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000323403a4044e23.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment